Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Change in Account Payables (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Change in Account Payables data on record, last reported at $32000.0 in Q3 2025.

  • For Q3 2025, Change in Account Payables fell 80.37% year-over-year to $32000.0; the TTM value through Sep 2025 reached -$233000.0, down 148.04%, while the annual FY2024 figure was -$73000.0, 83.99% up from the prior year.
  • Change in Account Payables reached $32000.0 in Q3 2025 per UTMD's latest filing, up from -$180000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $695000.0 in Q1 2022 and bottomed at -$826000.0 in Q3 2023.
  • Average Change in Account Payables over 5 years is -$1000.0, with a median of $32000.0 recorded in 2025.
  • Peak YoY movement for Change in Account Payables: tumbled 302.29% in 2021, then surged 1262.75% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at -$265000.0 in 2021, then surged by 71.32% to -$76000.0 in 2022, then surged by 436.84% to $256000.0 in 2023, then crashed by 217.97% to -$302000.0 in 2024, then surged by 110.6% to $32000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Account Payables were $32000.0 in Q3 2025, -$180000.0 in Q2 2025, and $217000.0 in Q1 2025.